Log in to save to my catalogue

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates...

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fa4ed4a3c9c4db28bbbc07074870b2a

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli

About this item

Full title

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli

Publisher

London: Nature Publishing Group UK

Journal title

Communications biology, 2021-05, Vol.4 (1), p.542-12, Article 542

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The increasing prevalence of antimicrobial resistance has become a global health problem.
Acinetobacter baumannii
is an important nosocomial pathogen due to its capacity to persist in the hospital environment. It has a high mortality rate and few treatment options. Antibiotic combinations can help to fight multi-drug resistant (MDR) bacterial...

Alternative Titles

Full title

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5fa4ed4a3c9c4db28bbbc07074870b2a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fa4ed4a3c9c4db28bbbc07074870b2a

Other Identifiers

ISSN

2399-3642

E-ISSN

2399-3642

DOI

10.1038/s42003-021-02074-5

How to access this item